Physician profile
Catherine Nipper
NPI 1962878884
$7,850.71
in general payments reported to CMS, 2019-2025
30 companies · $920 in 2025
The $920 reported for 2025 was more than what 95% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $945 · 2022: $869 · 2023: $3,902 · 2024: $1,216 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,733 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,950 · Travel and Lodging: $1,166 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,732.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,950.00 |
| Travel and Lodging | $1,165.73 |
| Education | $189.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,736.82 | 2022-2024 | |
| Abbvie INC. | $1,100.14 | 2021-2023 | |
| Astellas Pharma US INC | $452.38 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $333.50 | 2023-2025 | |
| Exeltis, USA INC. | $324.29 | 2021-2025 | Slynd |
| Organon LLC | $253.08 | 2021-2025 | Nexplanon |
| Biohaven Pharmaceutical Holding Company LTD. | $210.52 | 2022 | |
| Lilly USA, LLC | $189.21 | 2021-2025 | Zepbound |
| Millicent US INC | $162.95 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Sumitomo Pharma America, INC. | $134.40 | 2023-2025 | Myfembree |
| Ascend Therapeutics US, LLC | $126.05 | 2021-2023 | |
| Hologic Sales and Service, LLC | $108.85 | 2024-2025 | Aptima, Thinprep 2000 Processor, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $98.10 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $94.17 | 2021-2022 | |
| Novo Nordisk INC | $88.44 | 2023-2025 | Wegovy |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $86.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.49 | 2023-2024 | |
| Biohaven Pharmaceuticals, INC. | $36.08 | 2021 | |
| Evofem Biosciences, INC. | $35.79 | 2021-2025 | Phexxi, Solosec, Phexx |
| Axonics, INC. | $30.86 | 2024 | Bulkamid |
| Avion Pharmaceuticals | $30.85 | 2022-2023 | Balcoltra |
| Integra Lifesciences Corporation | $27.07 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| American Regent | $26.38 | 2025 | Injectafer |
| Ethicon US, LLC | $18.67 | 2023 | Ethicon, Stratafix |
| Boston Scientific Corporation | $18.17 | 2025 | General - Female Sui |
| Musculoskeletal Transplant Foundation INC. | $17.44 | 2023 | |
| Baxter Healthcare | $15.54 | 2023 | Tisseel |
| Cumberland Pharmaceuticals, INC. | $14.19 | 2024 | Caldolor |
| Kowa Pharmaceuticals America, INC. | $13.48 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Nipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.